TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment options for primary mediastinal B-cell lymphoma
Source: Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 17, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Treatment options for primary mediastinal B-cell lymphoma include the following:
Chemotherapy and rituximab.
Source links and citations
Chemotherapy and rituximab.
DA-EPOCH-R.
Chemotherapy and rituximab.
Lymphome Malin de Burkitt (LMB)–based chemotherapy plus rituximab.
Radiation therapy.
Source links and citations
Continue within this section
Preserved source evidence · Not medical advice